Does getting bloodwork twice a year actually protect TRT users?

What did @ryanover40prime actually say?

Ryan has been on TRT for four years, running 150mg of testosterone cypionate weekly, split into three doses. His levels were stable at 800-1,000 ng/dL. This year he quit drinking, lost 35 pounds, dropped 5% body fat, and added a GLP-1 receptor agonist called Rybelsus (semaglutide oral, which he calls "red a true tide"). He then got bloodwork done and found his testosterone had jumped to 1,300-1,600 ng/dL on the same dose. His takeaway: major lifestyle changes can shift your hormone levels dramatically, and "set it and forget it" TRT monitoring is a mistake.

That summary is accurate. He is not claiming the peptide fixed anything, not recommending doses, and not diagnosing anyone. He is telling his own story and advocating for regular bloodwork. That is the right framing for this kind of content.

Does the science back this up?

Yes, and this is actually well-documented. Body fat percentage has a direct relationship with testosterone metabolism, primarily through the enzyme aromatase, which converts testosterone to estradiol and is concentrated in adipose tissue. Less fat means less aromatase activity, which means more of your exogenous testosterone stays as testosterone rather than converting downstream.

A 2013 study by Fui, Dupuis, and Grossmann published in Clinical Endocrinology found that weight loss in obese men significantly raised total testosterone levels without any change in hormone therapy. That was in naturally producing men, but the mechanism applies to TRT users too. When you reduce the aromatase sink, the same exogenous dose produces higher circulating testosterone. A 2020 review by Corona et al. in the Journal of Sexual Medicine reinforced that adiposity is one of the strongest modifiers of testosterone bioavailability. Ryan is essentially describing this mechanism from lived experience without naming it, and he has it right.

What did they get wrong (or right)?

Mostly right, with one gap worth noting. Ryan correctly identifies that lifestyle changes altered his hormone levels on a fixed dose, and he correctly responded by getting bloodwork and flagging that an adjustment may be needed. That is textbook responsible TRT management.

What he does not address is the specific risk of running testosterone at 1,300-1,600 ng/dL. That range sits well above the standard reference ceiling for adult males, typically 1,100 ng/dL by most lab standards. Sustained levels in that range raise concerns about erythrocytosis (elevated red blood cell mass), elevated hematocrit, and cardiovascular strain. A 2018 paper by Bachman et al. in JAMA Internal Medicine found dose-dependent increases in hematocrit in men receiving testosterone, with levels above physiologic range carrying the most risk. Ryan mentions vague "side effects" but does not name them, and he does not say he actually adjusted his dose. The advice to get bloodwork is correct. The follow-through on what to do with alarming results needed more clarity.

What should you actually know?

If you are on TRT and you lose significant weight, change your body composition, quit alcohol, or add a GLP-1 medication, your testosterone levels can shift meaningfully on the exact same dose. This is not rare or surprising. It is physiology.

Alcohol suppresses testosterone production and increases aromatase activity. Quitting it removes that suppression. Fat loss reduces aromatase conversion. Both changes push circulating testosterone higher on a fixed exogenous dose. A 2012 study by Sierksma et al. in the Journal of Clinical Endocrinology and Metabolism confirmed alcohol's suppressive effect on the hypothalamic-pituitary-gonadal axis.

• Bloodwork every 3-6 months is the minimum standard when actively managing TRT, not just twice a year.
• If your levels climb above 1,100 ng/dL, that warrants a conversation with your prescriber about dose reduction, not just monitoring.
• Hematocrit is as important to test as total testosterone. Ryan does not mention it, but it should be part of every TRT panel.
• GLP-1 medications do not directly raise testosterone, but the weight loss they drive can do so indirectly through the aromatase mechanism.

Ryan's core message, that TRT requires active management and that life changes demand re-evaluation, is clinically sound. But "get bloodwork" is only useful if you act on what it shows.